Charts Actuate Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 02:54:03 21/10/2026 HKT			5-day change	1st Jan Change
0.6000 ^USD	+0.17%		+30.28%	-90.07%

10-07	Top Premarket Decliners	MT
09-09	Actuate Therapeutics Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with Ras Inhibitors Zoldonrasib and Daraxonrasib	CI

NasdaqUSD

Markets		Quality
Nasdaq	ACTU	Delayed
CBOE	ACTU	Real-time

ProRealTime Chart